Metabolic acidosis is a frequent and potentially serious medical condition that occurs when the body produces too much acid or when the kidneys are not able to effectively remove acid from the body. Non-anion gap metabolic acidosis (NAGMA) is a specific type of metabolic acidosis that occurs when there is an accumulation of organic acids, such as lactic acid, in the body. This type of acidosis is typically caused by a variety of medical conditions, such as kidney failure, certain medications, and certain genetic disorders. In this article, we will explore the causes and treatment options for NAGMA. We will discuss the various medical conditions that can cause NAGMA, the medications that can contribute to this condition, and the genetic disorders that can lead to NAGMA. We will also discuss the various treatments available for NAGMA, including lifestyle changes, medications, and other treatments.
Non-anion gap metabolic acidosis (NAGMA) is a type of metabolic acidosis that occurs when there is an accumulation of organic acids, such as lactic acid, in the body. This type of acidosis is typically caused by a variety of medical conditions, such as kidney failure, certain medications, and certain genetic disorders. NAGMA is a type of metabolic acidosis that is characterized by an abnormally high level of acid in the blood. The acidity of the blood is measured using the anion gap, which is the difference between the concentrations of the two main types of electrolytes in the blood: anions and cations. In NAGMA, the anion gap is normal, meaning that the levels of anions and cations are equal.
What Causes Non-Anion Gap Metabolic Acidosis?
NAGMA is typically caused by a variety of medical conditions, medications, and genetic disorders. The most common causes of NAGMA include:
Kidney Failure
Kidney failure is one of the most common causes of NAGMA. When the kidneys are not functioning properly, they are unable to filter out the acids that are produced in the body, leading to an accumulation of acid in the blood.
Medications
Certain medications, such as diuretics and antifungal medications, can also cause NAGMA. These medications can interfere with the body’s ability to filter out acids, leading to an accumulation of acid in the blood.
Genetic Disorders
Certain genetic disorders, such as inherited metabolic disorders, can also lead to NAGMA. These disorders can interfere with the body’s ability to process and eliminate acids, leading to an accumulation of acid in the blood.
The treatment of NAGMA depends on the underlying cause of the condition. In some cases, lifestyle changes may be enough to reduce the acid levels in the blood. In other cases, medications may be needed to reduce the acid levels in the blood. In some cases, other treatments, such as dialysis, may be necessary.
Non-anion gap metabolic acidosis (NAGMA) is a type of metabolic acidosis that occurs when there is an accumulation of organic acids, such as lactic acid, in the body. NAGMA is typically caused by a variety of medical conditions, medications, and genetic disorders. The treatment of NAGMA depends on the underlying cause of the condition, and may include lifestyle changes, medications, and other treatments.
1.
Even when they are not paying attention, children are still learning.
2.
Survivors of high-risk neuroblastoma face substantial late effects of modern therapies
3.
Kate Middleton Reaches Cancer Treatment Milestone
4.
Pulled Myeloma Drug Improves Survival in Trial
5.
Genetics and Genetic Testing to Inform Myelofibrosis Clinical Management.
1.
Breast Cancer Secrets: AI-Powered Precision Medicine
2.
Revolutionizing Oncology Trials: Optimization, Matching, Diversity, and Decentralization
3.
Surprising Symptoms of Prostate Cancer: What You Need to Know
4.
Empowering Lung Cancer Diagnosis Through the Synergy of Advanced Technologies and Artificial Intelligence
5.
Artificial Intelligence in Oncology: Current Trends, Challenges and Future Outlook
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part V
2.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part IV
3.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part IV
4.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
5.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part III
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation